Nidan Laboratories and Healthcare Limited (NSE:NIDAN)

NSE:NIDAN Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue	255.42	245.28	241.77	242.66	296.6
Revenue Growth	4.13%	1.45%	-0.36%	-18.19%	42.65%
Cost of Revenue	22.8	19.53	21.93	24.67	37.7
Gross Profit	232.62	225.74	219.84	217.99	258.9
Selling, General & Admin	43.83	46.73	48.62	51.58	38.54
Other Operating Expenses	140.13	126.71	106.78	98.37	126.22
Operating Expenses	202.94	197.53	184.06	180.94	191.07
Operating Income	29.68	28.22	35.78	37.05	67.83
Interest Expense	-18.61	-20.66	-20.86	-20.95	-24.35
Interest & Investment Income	18.26	20.46	26.46	28.84	0.05
Other Non Operating Income (Expenses)	-0.89	-0.73	0.05	0.48	-1.22
EBT Excluding Unusual Items	28.44	27.29	41.44	45.43	42.31
Gain (Loss) on Sale of Assets	-	0.32	-	2.69	2.89
Other Unusual Items	-4	-	-65.13	-	-
Pretax Income	24.44	27.6	-23.69	48.12	45.2
Income Tax Expense	9.38	7.83	8.64	12.72	18.58
Net Income	15.06	19.77	-32.32	35.4	26.63
Net Income to Common	15.06	19.77	-32.32	35.4	26.63
Net Income Growth	-23.82%	-	-	32.92%	15.66%
Shares Outstanding (Basic)	14	14	14	14	11
Shares Outstanding (Diluted)	14	14	14	14	11
Shares Change	-	-	-	21.22%	15.83%
EPS (Basic)	1.08	1.42	-2.33	2.55	2.32
EPS (Diluted)	1.08	1.42	-2.33	2.55	2.32
EPS Growth	-23.94%	-	-	9.76%	-0.24%

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	11.9	14.2	47.84	103.01	7.53
Free Cash Flow Per Share	0.86	1.02	3.44	7.41	0.66
Gross Margin	91.07%	92.04%	90.93%	89.83%	87.29%
Operating Margin	11.62%	11.50%	14.80%	15.27%	22.87%
Profit Margin	5.90%	8.06%	-13.37%	14.59%	8.98%
Free Cash Flow Margin	4.66%	5.79%	19.79%	42.45%	2.54%
EBITDA	48.61	52.26	64.35	67.9	94.06
EBITDA Margin	19.03%	21.31%	26.61%	27.98%	31.71%
D&A For EBITDA	18.93	24.05	28.57	30.84	26.23
EBIT	29.68	28.22	35.78	37.05	67.83
EBIT Margin	11.62%	11.50%	14.80%	15.27%	22.87%
Effective Tax Rate	38.38%	28.38%	-	26.44%	41.09%
Revenue as Reported	273.97	267.78	269.24	275.95	300.62

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 30, 2026

Data Sources Report a data error